• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

Assorted News (RegMed)

regenerative medicine tissue engineering stemcells regmed

  • Please log in to reply
178 replies to this topic

#151 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 20 November 2012 - 03:02 PM

BIOTIME, INC. : LifeMap Sciences, a Subsidiary of BioTime, Signs Definitive ...
4-traders - 43 minutes ago
LifeMap Sciences, Inc. a subsidiary of BioTime, Inc. (NYSE MKT: BTX) announced today that it has signed a definitive distribution agreement with ProSpec-Tany TechnoGene Ltd.
LifeMap Sciences, a Subsidiary of BioTime, Signs Definitive Distribution ... - MarketWatch (press release)

View the full article

#152 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 15 November 2012 - 09:20 PM

BIOTIME, INC. : BioTime Announces Non-Binding Letter of Intent with Geron ...
4-traders - Nov 15, 2012
BioTime, Inc. (NYSE MKT: BTX) and its recently formed subsidiary BioTime Acquisition Corporation (BAC) jointly announced today that they have entered into a non-binding letter of intent (LOI) with Geron Corporation. The LOI contains broad terms of a ...

View the full article

#153 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 20 November 2012 - 03:32 PM

LifeMap Sciences, a Subsidiary of BioTime, Signs Definitive Distribution ...
DailyFinance - Nov 20, 2012
(BUSINESS WIRE)-- LifeMap Sciences, Inc. a subsidiary of BioTime, Inc. (NYSE MKT: BTX) announced today that it has signed a definitive distribution agreement with ProSpec-Tany TechnoGene Ltd.

View the full article

sponsored ad

  • Advert

#154 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 27 November 2012 - 03:27 AM

BioTime Announces Passing of Director Abraham E. Cohen
DailyFinance - 1 hour ago
(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX) announced with sadness that Abraham (Barry) E. Cohen, a member of its Board of Directors, passed away on Thursday, November 22, 2012 at the age of 76.

View the full article

#155 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 27 November 2012 - 02:05 PM

BIOTIME, INC. : LifeMap Sciences, a Subsidiary of BioTime, Inc., Launches ...
4-traders - 1 hour ago
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the launch of LifeMap Discovery?
LifeMap Sciences, a Subsidiary of BioTime, Inc., Launches LifeMap Discovery ... - MarketWatch (press release)

View the full article

#156 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 27 November 2012 - 02:05 PM

BIOTIME, INC. : LifeMap Sciences, a Subsidiary of BioTime, Inc., Launches ...
4-traders - Nov 27, 2012
LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the launch of LifeMap Discovery?

View the full article

#157 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 29 November 2012 - 02:06 PM

BIOTIME, INC. : BioTime CEO Dr. Michael West to Present at World Stem Cell ...
4-traders - 2 hours ago
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, Ph.
BioTime CEO Dr. Michael West to Present at World Stem Cell Summit 2012 - MarketWatch (press release)

View the full article

#158 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 27 November 2012 - 03:27 AM

BioTime Announces Passing of Director Abraham E. Cohen
DailyFinance - Nov 27, 2012
(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX) announced with sadness that Abraham (Barry) E. Cohen, a member of its Board of Directors, passed away on Thursday, November 22, 2012 at the age of 76.

View the full article

#159 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 27 November 2012 - 03:05 AM

BIOTIME, INC. : BioTime Announces Passing of Director Abraham E. Cohen
4-traders - Nov 27, 2012
BioTime, Inc. (NYSE MKT: BTX) announced with sadness that Abraham (Barry) E. Cohen, a member of its Board of Directors, passed away on Thursday, November 22, 2012 at the age of 76.

View the full article

#160 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 24 April 2013 - 09:34 PM

Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported ...
Sacramento Bee - 3 hours ago
... Pipeline 94 10.4 Shenzhen Beike Biotechnology 95 10.4.1 Overview 95 10.4.2 Product Pipeline 95 10.5 JCR Pharmaceuticals 96 10.5.1 Overview 96 10.5.2 Product Pipeline 96 10.6 ES Cells International (Subsidiary of BioTime, Inc) 97 10.6.1 Overview 97 ...

View the full article

#161 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 10 May 2013 - 08:52 PM

Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert
Kapitall Blog (blog) - 19 hours ago
We know that former Geron CEO Tom Okarma, who is now part of BioTime Inc. (BTX), is in the process of resurrecting the Geron technology as part of a new company.

View the full article

#162 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 04 June 2013 - 01:16 PM

Vista Partners Publishes June 2013 Macroeconomic & Investment Newsletter
MarketWatch (press release) - 1 hour ago
The Companies featured in the FREE June 2013 Newsletter are: Acorn Energy, Inc., Mast Therapeutics, Inc., Algae.Tec Limited, Auxilio Inc., Digital Cinema Destinations Corporation, Ohr Pharmaceutical, Inc. (otcqb:OHRP), BioTime, Inc. (nyse mkt:BTX), ...

View the full article

#163 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 06 June 2013 - 04:44 PM

Blood: The Worldwide Market for Blood Products, Blood Testing, Blood ...
Sacramento Bee - 2 hours ago
CHAPTER EIGHT: COMPANY PROFILES AABB Abbott Laboratories America's Blood Centers American Red Cross Baxter International Bio-Rad Laboratories BioTime Inc. Gen-Probe Inc. /Hologic Fenwal/Fresenius Kabi Grifols Biologicals, Inc. Novartis ...

View the full article

#164 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 10 June 2013 - 05:38 PM

This Metric Says You Are Smart to Sell Anacor Pharmaceuticals Inc (ANAC)
Insider Monkey (blog) - Jun 10, 2013
These stocks are BioTime, Inc. (NYSEAMEX:BTX), Coronado Biosciences Inc (NASDAQ:CNDO), Repligen Corporation (NASDAQ:RGEN), Amyris Inc (NASDAQ:AMRS), and Insmed Incorporated (NASDAQ:INSM).

View the full article

#165 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 25 June 2013 - 09:36 AM

Stem Cells Market is Expected to Reach USD 119.51 Billion Globally in 2018 ...
PR Newswire UK (press release) - 2 hours ago
The key players in stem cell research and technology include Advanced Cell Technology Inc., Stem Cell Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., and Cellartis Ab among others. Related & Recently Published Reports by ...

View the full article

#166 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 24 June 2013 - 09:00 PM

Re-balancing the unbalanced…
Proactive Investors USA & Canada - Jun 24, 2013
Takara Bio Inc. announced today that it has granted Cellular Dynamics International, Inc. (CDI,) a non-exclusive, worldwide license to use Takara Bio's RetroNectin ® product.

View the full article

#167 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 01 July 2013 - 01:28 PM

ALBANY, New York, July 1, 2013 /PRNewswire/ --
PR Newswire UK (press release) - 4 hours ago
The company profiles for some of the key players, namely Advanced Cell Technology Inc., STEMCELL Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., Aastrom Biosciences Inc. and California Stem Cell Inc. in terms of company ...

View the full article

#168 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 03 July 2013 - 07:01 PM

We're still in a rough period…
Proactive Investors USA & Canada - 7 hours ago
BioTime (NYSEMKT: BTX) is DOWN… -0.10 to $3.99 with ... Bioheart, Inc. (OTCQB:BHRT) announced successful enrollment and randomization of the first patient in the Phase 3 MIRROR Trial using MyoCell® or muscle derived stem cells.

View the full article

#169 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 03 July 2013 - 12:35 AM

Regenerative Medicines: Bone and Joint Applications
Sacramento Bee - Jul 3, 2013
248 BIOMATLANTE 248 BIOMET, INC. 249 BIOMIMETIC THERAPEUTICS INC. 249 BIOSURFACE ENGINEERING TECHNOLOGIES (BIOSET) 250 BIOTIME INC. 251 BIOTISSUE TECHNOLOGIES GMBH 252 CAM BIOCERAMICS B.V. 252 CAPSTONE ...

View the full article

#170 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 03 July 2013 - 06:50 PM

Global Stem Cells Market - Industry Analysis, Size, Share, Growth, Trends and ...
SBWire (press release) - Jul 3, 2013
The company profiles for some of the key players, namely Advanced Cell Technology Inc., STEMCELL Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., Aastrom Biosciences Inc. and California Stem Cell Inc. in terms of company ...

View the full article

#171 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 12 July 2013 - 06:52 PM

A reverse split reduces the ratio of over-hangs
Proactive Investors USA & Canada - Jul 12, 2013
Today, NeoStem, Inc. (NYSE MKT: NBS) effected a 1-for-10 reverse stock split of its common stock which will be effective for trading purposes as of the commencement of trading on July 16, 2013.

View the full article

#172 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 31 July 2013 - 02:58 PM

Stem Cells Market Is Expected to Reach USD 119.51 Billion Globally in 2018 ...
SBWire (press release) - Jul 31, 2013
... driving the European stem cells market. The key players in stem cell research and technology include Advanced Cell Technology Inc., Stem Cell Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., and Cellartis Ab among others ...

View the full article

#173 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 02 August 2013 - 03:42 PM

Advanced Cell Technology, Inc. (ACTC.OB): Why Speculative Investors Can't ...
Seeking Alpha - Aug 2, 2013
In my recent Seeking Alpha interview on Friday, June 28, 2013, with Dr. West, who is the CEO of Biotime (BTX), he made some great observations of why an investment in stem cell companies may prove to be successful.

View the full article

#174 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 02 August 2013 - 02:43 PM

Stem Cells Market Research Report Published by Transparency Market Research
PR Web (press release) - Aug 2, 2013
The key players in stem cell research and technology include Advanced Cell Technology Inc., Stem Cell Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., and Cellartis Ab among others. Browse All Market Research Reports: ...

View the full article

#175 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 08 August 2013 - 11:37 PM

PDL BioPharma Announces Second Quarter 2013 Financial Results
PR Newswire (press release) - Aug 8, 2013
He joins PDL from BioTime, Inc. (NYSE MKT: BTX) where he served as CFO since 2011. Mr. Montez, who is a licensed certified public accountant, brings more than 13 years of experience overseeing accounting and financial functions and most recently ...

View the full article

#176 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 19 August 2013 - 10:19 PM

Stem Cell Markets
Sacramento Bee - Aug 19, 2013
... Coolmix 209 14.9.3 SepaxNet 2 210 14.10 BioTime, Inc. 210 14.10.1 PureStem Embryonic Progenitor Cells 210 14.10.1.1 Ectoderm Progenitors 210 14.10.1.2 Neural Crest Progenitors 211 14.10.1.3 Mesoderm Progenitors 211 14.10.2 PureStem Packages ...

View the full article

#177 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 29 August 2013 - 02:37 AM

AEZS Shifts Listing, AUXL Gets New Decision Date, Teva Hangs Up On RNN Deal
NASDAQ - 40 minutes ago
AUXL closed Wednesday's trading 2.74% higher at $17.99. BioTime Inc. ( BTX ) has received approval from the Spanish Agency of Medicines and Medical Devices to begin human clinical trials of Renevia stem cell delivery platform.

View the full article

#178 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 03 September 2013 - 10:06 PM

Abe Funds Stem Cells to Help Cure Japan Wasting Disease
Bloomberg - Sep 3, 2013
Menlo Park, California-based Geron Corp. (GERN) in January quit its first trial to develop spinal-cord injury treatment because of costs and sold the assets to BioTime Inc. (BTX). Hopes that cellular industries can fill a gap left by Japan's shrinking ...

View the full article

#179 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 05 September 2013 - 01:05 PM

Vista Partners Publishes September 2013 Macroeconomic & Investment ...
Wall Street Journal - 46 minutes ago
Tec Limited, Auxilio Inc. (OTCBB: AUXO), Digital Cinema Destinations Corporation, Ohr Pharmaceutical, Inc. (NASDAQ: OHRP), BioTime, Inc., Redhawk Resources, Inc. and Power Solutions International Inc. (NASDAQ: PSIX). Other companies mentioned are ...

View the full article





Also tagged with one or more of these keywords: regenerative medicine, tissue engineering, stemcells, regmed

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users